Skip to main content
. 2021 Sep 6;7(1):185. doi: 10.1186/s43094-021-00334-z

Fig. 3.

Fig. 3

Drug interaction sites used as control ligands identified by molecular docking. In the figure, Mpro SARS-COV-2 is presented docked with A N3 inhibitor; B chloroquine, C control ligands; D anakinra, E azithromycin, F baricitinib e G remdesivir